Immunocore Holdings plc — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Berman David M | HEAD OF R&D | Option Exercise | 572 | $17.46 | $9,987 | Dec 5, 2025 |
| Berman David M | HEAD OF R&D | Option Exercise | 5,521 | $17.46 | $96,397 | Nov 28, 2025 |
| Berman David M | HEAD OF R&D | Sale | 18,020 | $40.03 | $721,341 | Nov 25, 2025 |
| Berman David M | HEAD OF R&D | Sale | 61,849 | $35.23 | $2,178,940 | Sep 30, 2025 |
| Berman David M | HEAD OF R&D | Option Exercise | 22,532 | $17.46 | $393,409 | Sep 15, 2025 |
| Berman David M | HEAD OF R&D | Sale | 19,081 | $36.28 | $692,259 | Sep 11, 2025 |
| 667, L.P. | — | Purchase | 646,290 | $29.74 | $19,220,665 | Mar 17, 2025 |
| St Leger Tina Amber | CHIEF HR OFFICER | Sale | 4,375 | $64.06 | $280,263 | Apr 1, 2024 |
| Berman David M | HEAD OF R&D | Sale | 7,472 | $68.84 | $514,372 | Feb 28, 2024 |
| Berman David M | HEAD OF R&D | Sale | 4,448 | $69.45 | $308,914 | Feb 27, 2024 |
| St Leger Tina Amber | Chief HR Officer | Option Exercise | 4,375 | $29.87 | $130,681 | Jan 3, 2024 |